Login / Signup

SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.

Kanal SinghKevin RubensteinViviane CallierKaty Shaw-SalibaAdam RupertRobin DewarSylvain LaverdureHelene HighbargerPerrine LallemandMeei-Li HuangKeith R JeromeReigran SampoleoMargaret G MillsAlexander L GreningerKavita JunejaDanielle PorterConstance A BensonWalla DempseyHana M El SahlyChris FochtNikolaus JilgCatharine I PaulesRekha R RapakaTimothy M UyekiH Clifford LaneJohn H BeigelLori E Doddnull null
Published in: The Journal of infectious diseases (2024)
Reductions in SARS-CoV-2 RNA and antigen levels in blood correlated with clinical benefit from antiviral therapy.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • nucleic acid
  • coronavirus disease
  • type diabetes
  • adipose tissue
  • metabolic syndrome
  • cell therapy
  • drug induced
  • weight loss
  • skeletal muscle